![Emory Cardiology](/img/default-banner.jpg)
- 443
- 568 386
Emory Cardiology
United States
Registrace 15. 04. 2014
Emory Cardiology, a division of the Emory University School of Medicine, fully embraces all aspects of our tripartite mission of education, research, and patient care to train the next generation of academic cardiologists, bring cutting-edge discoveries from the bench to the bedside, and provide outstanding patient care.
Emory Cardiology Friday Fellows Journal Club 05-17-2024
Topic: REDUCE-AMI Trial
Speaker: Birju Rao, MD
Topic: An “Inclisiran First” Strategy vs Usual Care in Patients With Atherosclerotic Cardiovascular Disease
Speaker: Graham Smith, MD
Speaker: Birju Rao, MD
Topic: An “Inclisiran First” Strategy vs Usual Care in Patients With Atherosclerotic Cardiovascular Disease
Speaker: Graham Smith, MD
zhlédnutí: 911
Video
State-of-the-Art Surgical Coronary Revascularization
zhlédnutí 304Před 2 měsíci
Emory Cardiology Grand Rounds 05-06-2024 Speaker: John D. Puskas, MD, MSc, FACC, FACS
Carcinoid Heart Disease: The known and yet to be known.
zhlédnutí 803Před 2 měsíci
Emory Cardiology Friday Fellows Conference 05-03-2024 Speaker: Francisco Aguilar, MD
Novel Concepts of Tricuspid Regurgitation: Anatomy, Pathophysiology and Management
zhlédnutí 1,3KPřed 3 měsíci
Emory Cardiology Grand Rounds 04-22-2024 Speaker: Rebecca Hahn, MD, FACC, FESC, FASE
Emory Cardiology Friday Fellows Conference Journal Club 04-19-2024
zhlédnutí 1,1KPřed 3 měsíci
Topic: Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndrome (ULTIMAR-DAPT) trial Speaker: Muzamil A. Khawaja, MD Topic: Efficacy and Safety of Acoramidis in Transthyretin Amyloid Cardiomyopathy Speaker: Andrew Murphy, MD
The Ross Renaissance
zhlédnutí 197Před 3 měsíci
Emory Cardiology Grand Rounds 04-15-2024 Speaker: Joshua M. Rosenblum, MD, PhD
FMD SCAD 2024 09 Wenger Show Your Heart You Care
zhlédnutí 108Před 3 měsíci
FMD SCAD 2024 09 Wenger Show Your Heart You Care
FMD SCAD 2024 08 Rowe Anxiety and Depression
zhlédnutí 101Před 3 měsíci
FMD SCAD 2024 08 Rowe Anxiety and Depression
FMD SCAD 2024 07 Pregnancy and Contraception
zhlédnutí 85Před 3 měsíci
FMD SCAD 2024 07 Pregnancy and Contraception
FMD SCAD 2024 06 Nahab Aneurysm and Carotid Dissection
zhlédnutí 134Před 3 měsíci
FMD SCAD 2024 06 Nahab Aneurysm and Carotid Dissection
FMD SCAD 2024 05 Flood Heart Healthy Diet
zhlédnutí 144Před 3 měsíci
FMD SCAD 2024 05 Flood Heart Healthy Diet
FMD SCAD 2024 04 Mustapha SCAD Treatment
zhlédnutí 168Před 3 měsíci
FMD SCAD 2024 04 Mustapha SCAD Treatment
FMD SCAD 2024 03 LeLeiko SCAD Overview
zhlédnutí 183Před 3 měsíci
FMD SCAD 2024 03 LeLeiko SCAD Overview
In DanGer Shock Shock Territory: The Use of Microbial Flow Pump in Cardiogenic Shock From Acute MI
zhlédnutí 1,4KPřed 3 měsíci
In DanGer Shock Shock Territory: The Use of Microbial Flow Pump in Cardiogenic Shock From Acute MI
Beyond Echo: Use of Cardiac MR in Pericardial Disease
zhlédnutí 362Před 3 měsíci
Beyond Echo: Use of Cardiac MR in Pericardial Disease
From Prediction to Precision: AI's Evolution in Heart & Vascular Disease
zhlédnutí 452Před 3 měsíci
From Prediction to Precision: AI's Evolution in Heart & Vascular Disease
Bicuspid Aortic Aortopathy: Understanding and Management
zhlédnutí 1,2KPřed 4 měsíci
Bicuspid Aortic Aortopathy: Understanding and Management
Patent Ductus Arteriosus in Late Pregnancy
zhlédnutí 311Před 4 měsíci
Patent Ductus Arteriosus in Late Pregnancy
The Journey to better, more equitable health; Lessons learned from the Pandemic
zhlédnutí 174Před 4 měsíci
The Journey to better, more equitable health; Lessons learned from the Pandemic
Emory Cardiology Friday Fellows Conference - Journal Club 03-15-2024
zhlédnutí 657Před 4 měsíci
Emory Cardiology Friday Fellows Conference - Journal Club 03-15-2024
HIV and the Coronaries: More Than Your Average Risk Factor
zhlédnutí 190Před 4 měsíci
HIV and the Coronaries: More Than Your Average Risk Factor
Assessment and Mitigation of Lipid-Associated CVD Risk in Young Adults
zhlédnutí 529Před 4 měsíci
Assessment and Mitigation of Lipid-Associated CVD Risk in Young Adults
Case Discussion: Syncope in a 17-year-old Elite Athlete
zhlédnutí 841Před 4 měsíci
Case Discussion: Syncope in a 17-year-old Elite Athlete
Advances in Hypertension 2024: Will New Drugs and Renal Nerve Denervation Eliminate Disparities
zhlédnutí 1,2KPřed 4 měsíci
Advances in Hypertension 2024: Will New Drugs and Renal Nerve Denervation Eliminate Disparities
A critical appraisal of the quality of the trials is needed. Bempedoic acid did not have an effect on secondary prevention. This was not discussed in the NEJM article. Data sharing needs to be done or the results should not be published. Also BMJ article regarding Repatha demonstrated that the CRF didn’t match the results. Data sharing is required.
Thank you very much indeed for such an informative lecture. I started taking Mavacamten, here in the United Kingdom, only two weeks ago (we are behind the US in distributing this First in Class medication). So it is early days but I remain cautiously optimistic. Whilst I have tried to keep up with the trial data for these CMI medications, I found your discussion of the clinical management very helpful. The possibility of long-term remodelling remains tantalising, but for now I need to be cautiously optimistic about receiving improvements in my symptoms and NYHA status over the coming months.
Nice!
Nice presentation. Thank you
👌👌👌
CAC is a late manifestation of atherosclerosis. We don’t have to wait for CAC > 0 to treat the patient. The most spartan of diets associated with exercise would reduce LDL and Apo B to what level? 10%? 7%? It is impossible not to use drugs to reduce cholesterol and MACE.
Atherosclerosis is not a inexorable condition . Is there a level of ApoB that that if maintained throughout life would not let plaques to build up ? ApoB less than 55 mg/dl for instance .
Excellent presentation🐸❤️thank you